Trials / Completed
CompletedNCT01346033
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes
An Evaluation of a Non-invasive Diabetes Screening Device in Subjects With Type 2 Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- VeraLight, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.
Detailed description
Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this study is to correct an imbalance in the disease prevalence of the data set used to develop the SCOUT DS diabetes screening algorithm.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2011-05-02
- Last updated
- 2012-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01346033. Inclusion in this directory is not an endorsement.